Category Archives: Events

Latest From Events

Washington Gov. Jay Inslee to Keynote BIO Convention in China

Gov_Inslee_115x76

Next month, BIO will be hosting our 3rd Annual BIO Convention in China, November 11-13. We are very pleased that Washington Governor Jay Inslee will be joining us as our keynote speaker on November 12. “China is a rapidly growing market for America’s innovative biotechnology companies, including those in Washington State. As this market continues to expand, it will be increasingly important to develop collaborative relationships with the Chinese government, companies, and academic institutions. The BIO Convention Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

GAIN Act: A Great First Step

clinical-trials

With over 2 million infections – and 23,000 deaths – caused by antibiotic resistant bacteria each year in the US, everyone agrees there is an urgent need to find new, effective antibiotic therapies. One measure designed to spur such development is the Generating Antibiotics Incentives Now (GAIN) Act, signed into law last year. Given the growing threat posed by resistant bacteria, we decided to hold a workshop with leading experts about what effect the GAIN Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , ,

Biotech IPO Boom or Bubble? The Opening Plenary at the BIO Investor Forum

David Thomas

With 31 (and counting) life sciences companies having already placed IPOs on the market within the first 8 months of this year and many others lining up for S-1 filings, biotech is buzzing about a revival of the IPO market. Is it a bubble? David Thomas, director of Industry Research and Analysis at BIO took up these questions during the opening plenary lunch of the 12th Annual BIO Investor Forum. What’s his short answer? Not Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

BIO Investor Forum to Showcase NSF-funded Companies

150639480

No risk, no reward—that’s the concept driving the startups and entrepreneurs scheduled to present at next week’s 12th Annual BIO Investor Forum as a part of the newly-announced National Science Foundation (NSF) track of presenting companies. Expanding on the success of the Discovery Track Presentations, the 2013 BIO Investor Forum will feature a dedicated track of 10 NSF-funded companies focused on drug discovery, diagnostics and other related technologies. The companies are supported by the NSF Small Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Putting Patients First: Paving a Path to Useful CER

NPC_emailbanner_web

Comparative effectiveness research (CER) has the potential to improve health outcomes by helping people make better-informed decisions. But how do we know that CER will generate information that is useful? On September 30, in Washington, DC, you can be part of a conversation featuring a broad range of health care stakeholders—patients, providers, policymakers, payers, researchers, and those who fund research–by participating in an effort led by the National Health Council to create a framework to Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , ,